MP NHM signs cervical-cancer screening MoU; Rewa selected for planned pilot
In May 2026, the Madhya Pradesh National Health Mission (NHM) signed a memorandum of understanding with Hyderabad-based Bhargavi Health Care to support cervical-cancer screening and management in the state.
Planned Rewa pilot
The agreement identifies Rewa district as the pilot site and plans HPV DNA-based screening for approximately 10,000 women aged 25–65. The screenings are planned under the pilot; the agreement does not establish that they have begun.
Training and technical support
The NHM will select and train auxiliary nurse midwives (ANMs), staff nurses, community health officers and accredited social health activists (ASHA workers). Bhargavi Health Care will provide technical and training support.
Important Facts for Exams
- HPV risk groups: HPV types are classified as high-risk, probable high-risk or low-risk; types 16 and 18 are among those classed as high-risk.
- Cancer mechanism: High-risk HPV can integrate its DNA into host cells; its E6 and E7 proteins disrupt the tumour-suppressing proteins p53 and pRb.
- HPV test distinction: Unlike cytology, which examines cervical cells, HPV DNA testing detects genetic material from high-risk HPV, identifying infection rather than cellular abnormalities.
Category: Madhya Pradesh
Originally written on
May 16, 2026
and last modified on
November 20, 2026.
Tags: ASHA workers, Bhargavi Health Care, HPV DNA-based screening, Madhya Pradesh, National Health Mission, Rewa district